[{"address1": "1000 Skokie Boulevard", "address2": "Suite 350", "city": "Wilmette", "state": "IL", "zip": "60091", "country": "United States", "phone": "847 388 0349", "website": "https://www.monopartx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops MNPR-101-Zr, a clinical stage urokinase plasminogen activator receptor-targeted radiodiagnostic imaging agent; and MNPR-101-RIT, a late preclinical stage radiotherapeutic for advanced cancers. It also develops Camsirubicin, a Phase 1b clinical stage novel analog of doxorubicin, which is in Phase 1b clinical trial for the treatment of advanced soft tissue sarcoma; and MNPR-202, an analog of Camsirubicin to treat doxorubicin-and camsirubicin-resistant cancers. Monopar Therapeutics Inc. has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19; and the Cancer Science Institute of Singapore to evaluate the activity of MNPR-202 and related analogs in various types of cancer. The company was founded in 2014 and is headquartered in Wilmette, Illinois. Monopar Therapeutics Inc. is a subsidiary of Tacticgem LLC.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Dr. Christopher M. Starr Ph.D.", "age": 72, "title": "Co-Founder & Independent Executive Chairman of the Board", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 200000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Chandler D. Robinson M.B.A., M.D., M.Sc., MBA, MSc", "age": 40, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1984, "fiscalYear": 2023, "totalPay": 710500, "exercisedValue": 0, "unexercisedValue": 56986}, {"maxAge": 1, "name": "Mr. Andrew J. Cittadine M.B.A.", "age": 52, "title": "Chief Operating Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 416700, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Quan Anh Vu", "age": 54, "title": "CFO, Principal accounting officer & Principal financial officer", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Patrice P. Rioux M.D., Ph.D.", "age": 73, "title": "Acting Chief Medical Officer", "yearBorn": 1951, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 34.37, "open": 36.56, "dayLow": 34.5, "dayHigh": 42.896, "regularMarketPreviousClose": 34.37, "regularMarketOpen": 36.56, "regularMarketDayLow": 34.5, "regularMarketDayHigh": 42.896, "payoutRatio": 0.0, "beta": 1.194, "forwardPE": -18.176271, "volume": 37369, "regularMarketVolume": 37369, "averageVolume": 55827, "averageVolume10days": 27930, "averageDailyVolume10Day": 27930, "bid": 40.89, "ask": 43.31, "bidSize": 1, "askSize": 1, "marketCap": 261774128, "fiftyTwoWeekLow": 1.72, "fiftyTwoWeekHigh": 54.3, "fiftyDayAverage": 35.6904, "twoHundredDayAverage": 15.8867, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 175377760, "profitMargins": 0.0, "floatShares": 2994199, "sharesOutstanding": 6102530, "sharesShort": 51271, "sharesShortPriorMonth": 30636, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0084, "heldPercentInsiders": 0.3731, "heldPercentInstitutions": 0.4225, "shortRatio": 0.81, "shortPercentOfFloat": 0.0167, "impliedSharesOutstanding": 6102530, "bookValue": 1.403, "priceToBook": 30.574484, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -6474726, "trailingEps": -1.98, "forwardEps": -2.36, "lastSplitFactor": "1:5", "lastSplitDate": 1723507200, "52WeekChange": 7.9621906, "SandP52WeekChange": 0.07465422, "quoteType": "EQUITY", "currentPrice": 42.896, "targetHighPrice": 76.0, "targetLowPrice": 37.0, "targetMeanPrice": 53.25, "targetMedianPrice": 50.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 6020084, "totalCashPerShare": 1.141, "totalDebt": 0, "quickRatio": 5.361, "currentRatio": 5.405, "returnOnAssets": -0.59667, "returnOnEquity": -1.12038, "freeCashflow": -3873349, "operatingCashflow": -5951620, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MNPR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 24.80652, "regularMarketPrice": 42.896, "shortName": "Monopar Therapeutics Inc.", "longName": "Monopar Therapeutics Inc.", "corporateActions": [], "regularMarketTime": 1742411652, "exchange": "NCM", "messageBoardId": "finmb_304391755", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "marketState": "REGULAR", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1576765800000, "regularMarketChange": 8.526001, "regularMarketDayRange": "34.5 - 42.896", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 55827, "fiftyTwoWeekLowChange": 41.176, "fiftyTwoWeekLowChangePercent": 23.939533, "fiftyTwoWeekRange": "1.72 - 54.3", "fiftyTwoWeekHighChange": -11.403999, "fiftyTwoWeekHighChangePercent": -0.21001841, "fiftyTwoWeekChangePercent": 796.21906, "earningsTimestampStart": 1742992200, "earningsTimestampEnd": 1743424200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.98, "epsForward": -2.36, "epsCurrentYear": -1.77333, "priceEpsCurrentYear": -24.18952, "fiftyDayAverageChange": 7.2056007, "fiftyDayAverageChangePercent": 0.20189185, "twoHundredDayAverageChange": 27.0093, "twoHundredDayAverageChangePercent": 1.7001203, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "displayName": "Monopar Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-19"}]